Table 1

Causes of deaths according to time of event (≤ 3 years after transplantation vs > 3 years after HCT)

Cause of death≤ 3 y after HCT
> 3 y after HCT
G-PBMC (N = 81)BM (N = 91)G-PBMC (N = 51)BM (N = 48)
Nonrelapse     
    Noninfectious pneumonia 13 
    Sinusoidal obstruction syndrome 
    Multiorgan failure 
    Hemorrhage 
    Cardiac failure 
    GVHD with or without infection 
    Infection (without concurrent GVHD) 
    Secondary cancer 
    Other 
Relapse 11 16 
Total 30 43 
Cause of death≤ 3 y after HCT
> 3 y after HCT
G-PBMC (N = 81)BM (N = 91)G-PBMC (N = 51)BM (N = 48)
Nonrelapse     
    Noninfectious pneumonia 13 
    Sinusoidal obstruction syndrome 
    Multiorgan failure 
    Hemorrhage 
    Cardiac failure 
    GVHD with or without infection 
    Infection (without concurrent GVHD) 
    Secondary cancer 
    Other 
Relapse 11 16 
Total 30 43 

Overall, 5 of 172 patients were not treated per intent. The results for these patients were included in the intention-to-treat analysis according to their randomly assigned treatment. Two patients randomized to BM received G-PBMC, and 3 patients randomized to G-PBMC received BM; the latter 3 patients experienced late NRM (infection without GVHD, n = 2; pancreatitis, n = 1). Because of the small number of late (> 3 years after HCT) deaths, Table 1 shows causes of deaths according to types of stem cell product given (not based on intention to treat). Causes of late deaths were determined by retrospective review of medical records. In the G-PBMC group, causes of late NRM were bacterial pneumonia (n = 3), sepsis (n = 1), and bronchiolitis obliterans without apparent infection (n = 1). In the BM group, causes of late NRM were sepsis (n = 2), ovarian cancer (n = 1), pancreatitis (n = 1), and systemic sclerosis without apparent infection (n = 1).

or Create an Account

Close Modal
Close Modal